Search

Unlabelled: The aim of the study is to compare de results of the bone scintigraphy of prostate cancer patients in different age groups with their total PSA (PSAt) and with their histopathological test results. MATERIALS AND METODS: Of the 180 patients with prostate cancer who were analyzed by Scintiscan in the last five years in our laboratory, 86 have a known PSAt value, and of these, 55 have a known Gleason Score. The 180 patients were divided into three age groups: (1) < or equal 60 years; (2) 60-70 years and (3) >70 years. The 86 patients with a known PSAt were also divided into five groups according to their PSAt value and the 55 patients with a known Gleason Score were divided in three groups. The scintigraphy results included all the patients in 3 groups, according to the presence, the absence or the likelihood of having bone metastasis. The 33 patients with proven bone metastasis were divided, according to their numbers, into the four Soloway groups., Results: Among the patients with PSAt >20 ng/mL, considered high risk for bone metastases, according to the Recomandations of CCAF, 21 (32.81%) of the 64 patients do not show the presence of bone metastases. For PSAt >50 ng/mL, all 5 patients <60 years of age have metastases, while only 15 (62.5%) of the 24 patients over 70 years old have metastases and 1 (4%) has low likelihood. 6 (21.42%) of the 28 patients with PSAt > sau egal 100 ng/mL do not have metastases. 10 (43.4 %) of the 23 patients with a Gleason Score <7, considered low risk, do have metastases (6 patients--26%) or low probability of metastases (4 patients--17.4%)., Conclusions: Our study confirms that the probability of bone metastasis for a high PSAt value is reversely proportional to age. In our study there is no direct correlation between Gleason Score and the bone scan results.

Image processing for the imagistic medicine domain nuclear medicine have long time being realised through specifical protocols which rarely allowed the intervention of other informatical modalities. Processing depends first of all on the acquisition type. This paper presents the steps of one of the most complex image processing protocols, in the case of myocardial SPECT acquisition (Single Photon Emission Computed Tomography).

Achalasia is a mortality disorder described in 1674 by Willis. It has a small incidence in the general population. The main symptom is dysphagia. The golden standard for diagnosis is esophageal manometry. Esophageal scintigraphy is a non-invasive method of exploration: the technique is simple, it lasts five minutes and is more sensitive than the radiologic exam. The esophageal scintigraphy was made in the Nuclear Medicine Laboratory of the Sf. Spiridon Hospital using a gamma scann Diacam--Siemens. The parameters measured with esophageal scintigraphy are: esophageal transit time, residuary radioactivity. Our study included a number of 37 patients with achalasia with ages between 16 and 80 years (the average--47, 3 years). Our conclusions are the same with the data from literature.

The esophageal scintigraphy is a technique used to evaluate the motility and the clearance of the esophagus. The patients with achalasia of the cardia were evaluated, before treating them with pneumatic dilatation and after. The reason is to evaluate the efficiency of the pneumatic dilatation technique in the treatment of esophageal achalasia. The pneumatic dilatation with an instrument type Rigiflex is a well/handled and used technique in our clinic. In the study 22 patients were included and we had in view the esophageal transit time and the residuary radioactivity before and after the pneumatic dilatation. We established an important statistical improvement of the data obtained after the dilatation comparative with the data before the treatment (p < 0.01).

Pulmonary embolism is a cause of death and the most common pathological condition involving the lungs of hospitalized patients. Early detection can rise prognosis of survival. In this case presented below, a patient suspected of pulmonary embolism was sent to our department, for assessing the lung perfusion, performing the pulmonary perfusion scintigram with 99mTc-MAA for establishing a diagnosis. Lung imaging is a noninvasive technique without patient discomfort that objectively can depict the distribution of the radiopharmaceutical throughout the lungs. We conclude that multiple non segmental defects with no radiological abnormalities state that the probability of pulmonary embolism is lower than 20%.